Clinical trials are the cornerstone of medical advancements, providing essential data to determine the safety and efficacy of new treatments. The global clinical trials market is expected to reach USD 83.5 billion by 2028, highlighting the growing significance of well-planned trials. But, 86% of clinical trials experience delays, often due to poor planning. By implementing […]
Read More →Most errors and technical failures in clinical trials arise due to the improper selection of clinical trial designs. The clinical trial design selection will have a strong impact on the cost and time associated with clinical trials. The expected outcomes shall be thought out and carefully addressed while designing a clinical trial. The selection of […]
Read More →The US FDA recommends efficient clinical trial design strategies such as basket designs, and umbrella designs to expedite the development of oncology drugs and biologics. FDA also provides guidance and advice to sponsors of drugs and biologics for cancer treatment regarding the design and conduct of clinical trials, other than first-in-human (FIH) trials. In contrast […]
Read More →To make a clinical trial faster, cost-efficient, and more successful, it all starts with a strategic design of a clinical trial, and the sturdy trial design is essential to ensure a successful clinical outcome. A proper study design determines the fate of the clinical trial and its likeliness to be successful. A study design involves […]
Read More →